Michael F MacLean has an estimated net worth of $16.5 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., Verve Therapeutics, Inc., Avidity Biosciences, Inc., AKCEA THERAPEUTICS, INC., and Camp4 Therapeutics Corp.

2024 was Michael F MacLean's most active year for acquiring shares with 12 total transactions. Michael F MacLean's most active month to acquire stocks was the month of December. 2008 was Michael F MacLean's most active year for disposing of shares, totalling 19 transactions. Michael F MacLean's most active month to dispose stocks was the month of January. 2024 saw Michael F MacLean paying a total of $2,599,804.89 for 662,941 shares, this is the most they've acquired in one year. In 2024 Michael F MacLean cashed out on 659,371 shares for a total of $12,995,272.15, their largest year based on trade value.